Oncocyte IMDX
Oncocyte: quarterly report for the quarter ended Sep 30, 2022
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001493152-22-031415
- Document
- 10-Q
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2835) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.
- Immucell ICCC public float $51M, Jun 30, 2025
- Alpha Teknova TKNO public float $54M, Jun 30, 2025
- Biomerica BMRA public float $7M, Nov 28, 2025
- Cardio Diagnostics Holdings CDIO public float $6M, Jun 30, 2025
- Aspira Women's Health AWHL public float $5M, Jun 30, 2025
